Nilotinib differentially affects oligomeric alpha-synuclein and reduces phosphorylated neurofilaments and motor symptoms in Parkinson's disease with dementia and Lewy Body dementia.

Nilotinib differentially affects oligomeric alpha-synuclein and reduces phosphorylated neurofilaments and motor symptoms in Parkinson's disease with dementia and Lewy Body dementia. - 2017


Poster presented at

Powered by Koha